89 related articles for article (PubMed ID: 15314865)
1. [Perftoran in the endotoxicosis correction in purulent-inflammatory urological diseases].
Ushakova ND; Moroz VV; Andreeva II
Anesteziol Reanimatol; 2004; (3):59-62. PubMed ID: 15314865
[TBL] [Abstract][Full Text] [Related]
2. [Perfluorocarbonic compounds application as a new approach in pathogenic treatment of severe forms of viral hepatitis].
Kovelenov AIu; Lobzin IuV
Klin Med (Mosk); 2003; 81(5):47-51. PubMed ID: 12856570
[TBL] [Abstract][Full Text] [Related]
3. [Changes in the cardiac hemodynamics and coronary blood flow in acute myocardial infarction due to perftoran].
Aliev OM
Anesteziol Reanimatol; 2004; (3):62-3. PubMed ID: 15314866
[TBL] [Abstract][Full Text] [Related]
4. [Theoretically probable assessment of the effectiveness of individualized combined antibiotic therapy of patients with suppurative inflammatory processes].
Finn GR; Kolchin AA; Teterina LM
Antibiotiki; 1975 Mar; 20(3):271-5. PubMed ID: 1094940
[TBL] [Abstract][Full Text] [Related]
5. [Pathophysiological aspects of endotoxicosis complicated with purulent infection of the foot and correction of endotoxicosis with conventional treatment and with application of ozonized physiological solution in patients suffering from diabetes mellitus].
Gazin IK
Patol Fiziol Eksp Ter; 2008; (4):23-5. PubMed ID: 19198268
[TBL] [Abstract][Full Text] [Related]
6. [Effect of perftoran on microcirculation and target organs in early atherogenesis].
Pozdniakov OM; Klimenko ED; Kobozeva LP; Michunskaia AB; Babakova LL; Leskova GF; Khugaeva VN; Moroz VV
Patol Fiziol Eksp Ter; 2003; (4):15-8. PubMed ID: 14682263
[TBL] [Abstract][Full Text] [Related]
7. [The effect of perftoran on the morphofunctional status of the digestive system organs in experimental duodenal ulcer].
Karimov KhIa; Daminov ShN; Khoroshaev VA
Eksp Klin Farmakol; 1999; 62(4):33-6. PubMed ID: 10513333
[TBL] [Abstract][Full Text] [Related]
8. [Immunocorrectors in the complex treatment of postoperative suppurative-inflammatory complications in surgical patients and monitoring of immunological parameters].
Buniatian AA; Inviiaeva EV; Nikoda VV; Vinnitskiĭ LI
Anesteziol Reanimatol; 2004; (5):79-83. PubMed ID: 15573734
[TBL] [Abstract][Full Text] [Related]
9. Clinical results of the application of perftoran for the treatment of odontogenous abcesses and phlegmons in the maxillofacial region.
Durnovo EA; Furman IV; Pushkin SY; Maslennikov IA; Bondar OG; Ivanitsky GR
J Craniomaxillofac Surg; 2008 Apr; 36(3):161-172. PubMed ID: 18353665
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin ameliorates renal dysfunction during endotoxaemia.
Mitra A; Bansal S; Wang W; Falk S; Zolty E; Schrier RW
Nephrol Dial Transplant; 2007 Aug; 22(8):2349-53. PubMed ID: 17438005
[TBL] [Abstract][Full Text] [Related]
11. Changing bacterial isolates and antibiotic sensitivities of purulent dacryocystitis.
Briscoe D; Rubowitz A; Assia EI
Orbit; 2005 Jun; 24(2):95-8. PubMed ID: 16191795
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis and treatment of acute epididymoorchitis].
Arbuliev MG; Arbuliev KM; Gadzhiev DP; Abunimekh BKh
Urologiia; 2008; (3):49-52. PubMed ID: 18669349
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidylcholine reduces the organ injury and dysfunction in rodent models of gram-negative and gram-positive shock.
Murch O; Collin M; Sepodes B; Foster SJ; Mota-Filipe H; Thiemermann C
Br J Pharmacol; 2006 Jul; 148(6):769-77. PubMed ID: 16751791
[TBL] [Abstract][Full Text] [Related]
14. Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.
Safdar A; Rodriguez GH; Lichtiger B; Dickey BF; Kontoyiannis DP; Freireich EJ; Shpall EJ; Raad II; Kantarjian HM; Champlin RE
Cancer; 2006 Jun; 106(12):2664-71. PubMed ID: 16691620
[TBL] [Abstract][Full Text] [Related]
15. [The leukocytic index of intoxication and some blood parameters in the evaluation of the severity of inflammatory, purulent, and pyodestructive diseases at various sites and in the determination of their prognosis].
Ostrovskiĭ VK; Mashchenko AV; Iangolenko DV; Makarov SV
Anesteziol Reanimatol; 2005; (6):25-9. PubMed ID: 16499101
[TBL] [Abstract][Full Text] [Related]
16. Strong inflammatory cytokine response in male and strong anti-inflammatory response in female kidney transplant recipients with urinary tract infection.
Sadeghi M; Daniel V; Naujokat C; Wiesel M; Hergesell O; Opelz G
Transpl Int; 2005 Feb; 18(2):177-85. PubMed ID: 15691270
[TBL] [Abstract][Full Text] [Related]
17. Pro- and anti-inflammatory cytokines in chronic pediatric dialysis patients: effect of aspirin.
Goldstein SL; Leung JC; Silverstein DM
Clin J Am Soc Nephrol; 2006 Sep; 1(5):979-86. PubMed ID: 17699316
[TBL] [Abstract][Full Text] [Related]
18. [The influence of perftoran on the course of acute pulmonary injury syndrome in patients with destructive pancreatitis].
Shevchuk I; Titov I
Klin Khir; 2001 Mar; (3):12-5. PubMed ID: 11482206
[TBL] [Abstract][Full Text] [Related]
19. Tigecycline: a novel glycylcycline antibiotic.
Zhanel GG; Karlowsky JA; Rubinstein E; Hoban DJ
Expert Rev Anti Infect Ther; 2006 Feb; 4(1):9-25. PubMed ID: 16441206
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and risk factors of colistin-induced nephrotoxicity.
Kim J; Lee KH; Yoo S; Pai H
Int J Antimicrob Agents; 2009 Nov; 34(5):434-8. PubMed ID: 19726164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
